SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Andreas Samson who wrote (18873)2/17/1999 9:09:00 PM
From: Mkilloran  Read Replies (2) | Respond to of 23519
 
Andreas...L Wilson statements were worst case IMO. We have already seen several EU countries license MUSE. Expect more very soon.
The quicker they launch the faster they use up supplies and need to reorder.

Key words from Wilson were:
"do not anticipate SIGNIFICANT ADDITIONAL shipments to partners until second half of 1999"

Not zero, zip, none,......

Based on sales in UK,Sweden and Switzerland in the 3rd qtr 1998 sales in EUROPE by Astra/Zeneca could be 5-6 times higher than they were in the 3rd qtr 1998 by the 3rd qtr 1999. Now that is SIGNIFICANT.......



To: Andreas Samson who wrote (18873)2/17/1999 9:24:00 PM
From: VLAD  Respond to of 23519
 
Andreas,

What is Leland Wilson's definition of "significant"????

Is significant more than $2M in international sales? $4M? $6M? I don't know. But I do know he doesn't know the meaning of "significant" as demonstrated in this December 17, 1998 press release:

biz.yahoo.com

Note that Leland Wilson says, "Although we are not prepared at this time to announce a partner, we have made SIGNIFICANT progress in these negotiations."

So if Leland knows the meaning of "significant", then WHERE IS OUR DOMESTIC PARTNERING AGREEMENT?

You see, he doesn't even know what he is talking about. Here we are 2 months later and where are the results of our SIGNIFICANT progress?

You mean you actually bought into Vivus thinking that they would sell "significant" quantities of MUSE on their own without a partner???

Shame on you Andreas! I thought you knew better.

The bottom line is that you are correct in saying that at status quo Q1 earnings will be lower than Q4. I can't argue that point but I CAN say this: even so IMHO it does NOT justify a $2.00/share stock. Look at all the internet crap and the valuations etc... and then justify for me the current Vivus price. Better yet, look over my past comparison of Vivus to CEPH and LIPO and tell me how you can justify the current Vivus share price based on comparitible valuations!



To: Andreas Samson who wrote (18873)2/17/1999 9:40:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
Looks like the third world doctors have more common sense than the American medical community:

africanews.org